<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
      <channel>
        <title>Latest articles from PMD</title>
        <link>http://www.pmdcentral.com</link>
        <description>
          Latest articles from PMD
        </description>
  
        <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/LatestFromPmd" type="application/rss+xml" /><feedburner:browserFriendly></feedburner:browserFriendly><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item>
          <title>Bid to restrict industry-backed CME rebuffed, again</title>
          <description>A third attempt by an AMA ethics council asking physicians and medical institutions to curb industry funding for professional educational activities was rebuffed yesterday.</description>
          <link>http://www.pmdcentral.com/Bid-to-restrict-industry-backed-CME-rebuffed-again/article/157524/</link>
          <pubDate>Tue, 10 Nov 2009 15:18:11 GMT</pubDate>
        </item>
  
        <item>
          <title>Pfizer shrinks R&amp;D operations</title>
          <description>Pfizer will shrink the square footage of its global R&amp;D operation by 35% as it absorbs Wyeth, sharply reducing some sites, shuttering others and prompting an as-yet unspecified number of layoffs.</description>
          <link>http://www.pmdcentral.com/Pfizer-shrinks-RD-operations/article/157434/</link>
          <pubDate>Mon, 09 Nov 2009 14:44:54 GMT</pubDate>
        </item>
  
        <item>
          <title>PhRMA: use FDA logo for link to PI, patient info online</title>
          <description>PhRMA called for FDA to develop an agency icon or bug that drugmakers could use on their websites to link to agency-approved product information and patient medical guides.</description>
          <link>http://www.pmdcentral.com/PhRMA-use-FDA-logo-for-link-to-PI-patient-info-online/article/157414/</link>
          <pubDate>Mon, 09 Nov 2009 13:17:33 GMT</pubDate>
        </item>
  
        <item>
          <title>EMD Serono film contest flags infertility</title>
          <description>EMD Serono extended its "In the Know" infertility awareness effort with a short film festival, inviting couples who've struggled with infertility to submit 5-8 minute videos about their experiences.</description>
          <link>http://www.pmdcentral.com/EMD-Serono-film-contest-flags-infertility/article/157387/</link>
          <pubDate>Mon, 09 Nov 2009 11:26:30 GMT</pubDate>
        </item>
  
        <item>
          <title>IMS Health purchased for $5.2 billion</title>
          <description>Marketing research giant IMS Health will be acquired by private equity firm TPG Capital and the Canadian Pension Plan Investment Board, a Toronto-based investment management organization, for $5.2 billion.</description>
          <link>http://www.pmdcentral.com/IMS-Health-purchased-for-52-billion/article/157250/</link>
          <pubDate>Fri, 06 Nov 2009 11:59:52 GMT</pubDate>
        </item>
  
        <item>
          <title>In DTC TV, longer doesn't have to mean less memorable, says Nielsen</title>
          <description>Prescription drug advertisers are running longer broadcast spots to accommodate more expansive fair balance statements, a Nielsen IAG analysis suggests, as 75-second spots proliferate.</description>
          <link>http://www.pmdcentral.com/In-DTC-TV-longer-doesnt-have-to-mean-less-memorable-says-Nielsen/article/157161/</link>
          <pubDate>Thu, 05 Nov 2009 14:14:21 GMT</pubDate>
        </item>
  
        <item>
          <title>AAFP pact with Coke distasteful to some</title>
          <description>An alliance with the nation's largest soft drink maker to sponsor advice on sugar-free alternatives has spurred criticism of the American Academy of Family Physicians (AAFP).</description>
          <link>http://www.pmdcentral.com/AAFP-pact-with-Coke-distasteful-to-some/article/157141/</link>
          <pubDate>Thu, 05 Nov 2009 11:00:26 GMT</pubDate>
        </item>
  
        <item>
          <title>Pharmapalooza 2 — six firms rock for charity</title>
          <description>Six healthcare agencies will plug in their amps and battle it out for musical supremacy -- and for charity -- when Pharmapalooza 2, the industry's band contest, takes over the legendary B.B. King Blues Club &amp; Grill in New York City on Thursday, Nov. 5 at 8pm.</description>
          <link>http://www.pmdcentral.com/Pharmapalooza-2-six-firms-rock-for-charity/article/157068/</link>
          <pubDate>Wed, 04 Nov 2009 14:08:58 GMT</pubDate>
        </item>
  
        <item>
          <title>CEOs trump movie stars among celeb endorsers, says survey</title>
          <description>Mulling celebrity spokes-candidates for an ad campaign? Consider this: business leaders are more persuasive than athletes, movie stars or musicians, according to a Harris Interactive poll conducted on behalf of Adweek.</description>
          <link>http://www.pmdcentral.com/CEOs-trump-movie-stars-among-celeb-endorsers-says-survey/article/157067/</link>
          <pubDate>Wed, 04 Nov 2009 13:56:08 GMT</pubDate>
        </item>
  
        <item>
          <title>Lupus drug launch focuses on social media, advocacy orgs</title>
          <description>Human Genome Sciences and GlaxoSmithKline said online communication will play a key role in the upcoming launch of lupus drug Benlysta. The companies are considering various web channels, from advocacy groups to social media.</description>
          <link>http://www.pmdcentral.com/Lupus-drug-launch-focuses-on-social-media-advocacy-orgs/article/157065/</link>
          <pubDate>Wed, 04 Nov 2009 13:31:26 GMT</pubDate>
        </item>
  
        <item>
          <title>Ohr Pharmaceutical CEO Announces Completion of Biotech Transformation With Acquisition of Phase II Drugs</title>
          <description>Ohr acquired OHR/AVR118 and EVIZON</description>
          <link>http://www.pmdcentral.com/Ohr-Pharmaceutical-CEO-Announces-Completion-of-Biotech-Transformation-With-Acquisition-of-Phase-II-Drugs/article/157478/</link>
          <pubDate>Tue, 10 Nov 2009 09:31:37 GMT</pubDate>
        </item>
  
        <item>
          <title>Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic</title>
          <description>Bristol-Myers Squibb buys rights to RA drug for $85 million</description>
          <link>http://www.pmdcentral.com/Bristol-Myers-Squibb-and-Alder-Biopharmaceuticals-Enter-Global-Agreement-on-Rheumatoid-Arthritis-Biologic/article/157477/</link>
          <pubDate>Tue, 10 Nov 2009 09:21:51 GMT</pubDate>
        </item>
  
        <item>
          <title>Enzon Announces Agreement to Sell Specialty Pharmaceutical Business</title>
          <description>sigma-tau to acquire business for approximately $327 million in cash plus royalties</description>
          <link>http://www.pmdcentral.com/Enzon-Announces-Agreement-to-Sell-Specialty-Pharmaceutical-Business/article/157366/</link>
          <pubDate>Mon, 09 Nov 2009 09:11:48 GMT</pubDate>
        </item>
  
      </channel>
    </rss>
